Access to Medicine Index Partners

Partners

Since 2003, extensive consultation with many stakeholders to the cause of improving access to medicines has produced a broad consensus on the value and basic characteristics of the Access to Medicine Index.

Support has come from representatives of the investor community, NGOs, academia, governments as well as the pharmaceutical industry. All of these stakeholders will continue to be invited to contribute to the further development and fine-tuning of the Index.

Among the stakeholders that were invited to share their thoughts and comments during the buildup of the Index were:

NGOs and academia

Governments

World Health Organization (WHO)
UK Department for International Development (DFID)
Netherlands Ministry of Public Health (VWS)

Pharmaceutical industry

The Access to Medicine Foundation regards cooperation and general support from the pharmaceutical industry as crucial to the ultimate success of the Index. Input was asked and received from industry associations and individual companies.
Feedback was received from, among others:

Investor community

The investor community will be a key user of the Access to Medicine Index. In the run-up to the launch of the Index, the Foundation consulted with:

Financial partners

To fully ensure its independence, the Access to Medicine Foundation does not receive any funding from pharmaceutical companies. Its development and maintenance has up until now been generously supported by the following sponsors through financial and/or in-kind backing:

> more

Investor support

The investor community has shown strong interest in the Access to Medicine Index. Twelve global investors have already backed the Index by signing on to the Investor Statement.